Sep 12, 2019
NanoViricides, Inc. Announces One-for-Twenty Reverse Stock Split
Aug 26, 2019
NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND
Aug 05, 2019
NanoViricides Reports Its First Drug Candidate is on Track with GLP Safety/Toxicology Studies toward Human Clinical Trials
Jun 10, 2019
NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors
Apr 16, 2019
NanoViricides Submits Pre-IND Briefing Documents to the US FDA
Feb 11, 2019
NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Jan 02, 2019
NanoViricides, Inc. CEO Dr. Taraporewala To Present At The Biotech Showcase(TM) Investment Conference In San Francisco on January 7, 2019
Oct 29, 2018
NanoViricides, Inc. Appoints Mr. James Sapirstein to its Board of Directors
Oct 22, 2018
NanoViricides CEO Dr. Irach Taraporewala Presents a Letter to Shareholders
Oct 15, 2018
NanoViricides Has Filed its Annual Report, Company Reports Strong Progress in Advancement of HerpeCide Program
Sep 28, 2018
NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1
Sep 05, 2018
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th
Aug 07, 2018
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study
Jul 23, 2018
NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO
May 14, 2018
NanoViricides Provides Update, Says Company is Stable and is Moving Steadily towards Clinical Trials
Apr 09, 2018
NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroCap Conference in New York City Today
Mar 19, 2018
NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin
Feb 21, 2018
NanoViricides Files Quarterly Report for Period Ending December 31, 2017
Dec 06, 2017
Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates